1
|
O'Connor TF, Chatterjee S, Lam J, de la Ossa DHP, Martinez-Peyrat L, Hoefnagel MH, Fisher AC. An examination of process models and model risk frameworks for pharmaceutical manufacturing. Int J Pharm X 2024; 8:100274. [PMID: 39206253 PMCID: PMC11350267 DOI: 10.1016/j.ijpx.2024.100274] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/31/2024] [Revised: 08/05/2024] [Accepted: 08/05/2024] [Indexed: 09/04/2024] Open
Abstract
Process models are a growing tool for pharmaceutical manufacturing process design and control. The Industry 4.0 paradigm promises to increase the amount of data available to understand manufacturing processes. Tools such as Artificial Intelligence (AI) might accelerate process development and allow better predictions of process trajectories. Several examples of process improvements realized through the application of process models have been shown in lyophilization, chromatography, fluid bed drying, bioreactor control, continuous direct compression, and wet granulation. An important consideration of implementing a process model is determining the impact of the model on the quality of the product and the risks associated with model maintenance over the product lifecycle. Several regulatory documents address risk-based considerations for process models. This work discusses existing risk-based frameworks for model validation and lifecycle maintenance that could aid the adoption of process models in pharmaceutical manufacturing. Hypothetical case studies illustrate the implications of applying a model risk framework to facilitate model validation and lifecycle maintenance in the manufacture of pharmaceuticals and biological products.
Collapse
Affiliation(s)
- Thomas F. O'Connor
- Food and Drug Administration, Center for Drug Evaluation and Research, Silver Spring, MD 20993, United States
| | - Sharmista Chatterjee
- Food and Drug Administration, Center for Drug Evaluation and Research, Silver Spring, MD 20993, United States
| | - Johnny Lam
- Food and Drug Administration, Center for Biologics Evaluation and Research, Silver Spring, MD 20993, United States
| | | | - Leticia Martinez-Peyrat
- French National Agency for Medicines and Health Products Safety, F-93285, Saint-Denis, France
- Quality Innovation Group (QIG), European Medicines Agency (EMA), Amsterdam, the Netherlands
| | - Marcel H.N. Hoefnagel
- Quality Innovation Group (QIG), European Medicines Agency (EMA), Amsterdam, the Netherlands
- CBG-MEB (Medicines Evaluation Board), Utrecht, the Netherlands
| | - Adam C. Fisher
- Food and Drug Administration, Center for Drug Evaluation and Research, Silver Spring, MD 20993, United States
| |
Collapse
|
2
|
Jolliffe HG, Prostredny M, Mendez Torrecillas C, Bordos E, Tierney C, Ojo E, Elkes R, Reynolds G, Li Song Y, Meir B, Fathollahi S, Robertson J. A modified Kushner-Moore approach to characterising small-scale blender performance impact on tablet compaction. Int J Pharm 2024; 659:124232. [PMID: 38759740 DOI: 10.1016/j.ijpharm.2024.124232] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/30/2024] [Revised: 05/02/2024] [Accepted: 05/14/2024] [Indexed: 05/19/2024]
Abstract
Continuous Direct Compaction (CDC) has emerged as a promising route towards producing solid dosage forms while reducing material, development time and energy consumption. Understanding the response of powder processing unit operations, especially blenders, is crucial. There is a substantial body of work around how lubrication via batch blender operation affects tablet critical quality attributes such as hardness and tensile strength. But, aside from being batch operations, the design of these blenders is such that they operate with low-shear, low-intensity mixing at Froude number values significantly below 0.4 (Froude number Fr being the dimensionless ratio of inertial to gravitational forces). The present work explores the performance of a mini-blender which has a fundamentally different mode of operation (static vessel with rotating blades around a mixing shaft as opposed to rotating vessel with no mixing shaft). This difference allows a substantially wider operating range in terms of speed and shear (and Fr values). The present work evaluates how its performance compares to other blenders studied in the literature. Tablet compaction data from blends produced at various intensities and regimes of mixing in the mini-blender follow a common trajectory. Model equations from literature are suitably modified by inclusion of the Froude number Fr, but only for situations where the Froude number was sufficiently high (1 < Fr). The results suggest that although a similar lubrication extent plateau is eventually reached it is the intensity of mixing (i.e. captured using the Froude number as a surrogate) which is important for the lubrication dynamics in the mini-blender, next to the number of revolutions. The degree of fill or headspace, on the other hand, is only crucial to the performance of common batch blenders. Testing using alternative formulations shows the same common trend across mixing intensities, suggesting the validity of the approach to capture lubrication dynamics for this system.
Collapse
Affiliation(s)
- Hikaru G Jolliffe
- CMAC, Technology and Innovation Centre, 99 George Street, Glasgow G1 1RD, UK
| | - Martin Prostredny
- CMAC, Technology and Innovation Centre, 99 George Street, Glasgow G1 1RD, UK
| | | | - Ecaterina Bordos
- CMAC, Technology and Innovation Centre, 99 George Street, Glasgow G1 1RD, UK
| | - Collette Tierney
- CMAC, Technology and Innovation Centre, 99 George Street, Glasgow G1 1RD, UK
| | - Ebenezer Ojo
- CMAC, Technology and Innovation Centre, 99 George Street, Glasgow G1 1RD, UK
| | - Richard Elkes
- GSK Ware R&D, Harris's Lane, Ware, Hertfordshire SG12 0GX, UK
| | - Gavin Reynolds
- Oral Product Development, PT&D, Operations, AstraZeneca UK Limited, Charter Way, Macclesfield SK10 2NA, UK
| | - Yunfei Li Song
- GSK Ware R&D, Harris's Lane, Ware, Hertfordshire SG12 0GX, UK
| | - Bernhard Meir
- Gericke AG, Althardstrasse 120, CH-8105 Regensdorf, Switzerland
| | - Sara Fathollahi
- DFE Pharma GmbH & Co. KG, Kleverstrasse 187, 47568 Goch, Germany
| | - John Robertson
- CMAC, Technology and Innovation Centre, 99 George Street, Glasgow G1 1RD, UK.
| |
Collapse
|
3
|
Bekaert B, Janssen P, Fathollahi S, Vanderroost D, Roelofs T, Dickhoff B, Vervaet C, Vanhoorne V. Batch vs. continuous direct compression - a comparison of material processability and final tablet quality. Int J Pharm X 2024; 7:100226. [PMID: 38235316 PMCID: PMC10792456 DOI: 10.1016/j.ijpx.2023.100226] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/10/2023] [Revised: 12/06/2023] [Accepted: 12/18/2023] [Indexed: 01/19/2024] Open
Abstract
In this study, an in-depth comparison was made between batch and continuous direct compression using similar compression set-ups. The overall material processability and final tablet quality were compared and evaluated. Correlations between material properties, process parameters and final tablet properties were made via multivariate data analyses. In total, 10 low-dosed (1% w/w) and 10 high-dosed (40% w/w) formulations were processed, using a total of 10 different fillers/filler combinations. The trials indicated that the impact of filler type, drug load or process settings was similar for batch and continuous direct compression. The main differentiator between batch and continuous was the flow dynamics in the operating system, where properties related to flow, compressibility and permeability played a crucial role. The less consistent flow throughout a batch process resulted in a significantly higher variability within the tablet press (σCF) and for the tablet quality responses (σMass, σTS). However, the better controlled blending procedure prior to batch processing was reflected in a more consistent API concentration variability. Overall, the comparison showed the benefits of selecting appropriate excipients and process settings to achieve a specific outcome, keeping in mind some key differentiators between both processes.
Collapse
Affiliation(s)
- B. Bekaert
- Laboratory of Pharmaceutical Technology, Department of Pharmaceutics, Ghent University, Ottergemsesteenweg 460, B-9000 Ghent, Belgium
| | - P.H.M. Janssen
- Department of Pharmaceutical Technology and Biopharmacy, University of Groningen, Antonius Deusinglaan 1, 9713 AV Groningen, the Netherlands
- DFE Pharma, Klever Strasse 187, 47568 Goch, Germany
| | | | - D. Vanderroost
- GEA Process Engineering, Keerbaan 70, B-2160 Wommelgem, Belgium
| | - T. Roelofs
- DFE Pharma, Klever Strasse 187, 47568 Goch, Germany
| | | | - C. Vervaet
- Laboratory of Pharmaceutical Technology, Department of Pharmaceutics, Ghent University, Ottergemsesteenweg 460, B-9000 Ghent, Belgium
| | - V. Vanhoorne
- Laboratory of Pharmaceutical Technology, Department of Pharmaceutics, Ghent University, Ottergemsesteenweg 460, B-9000 Ghent, Belgium
| |
Collapse
|
4
|
Kobayashi Y, Kim S, Nagato T, Oishi T, Kano M. Feed factor profile prediction model for two-component mixed powder in the twin-screw feeder. Int J Pharm X 2024; 7:100242. [PMID: 38601059 PMCID: PMC11004622 DOI: 10.1016/j.ijpx.2024.100242] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/08/2023] [Revised: 03/14/2024] [Accepted: 03/28/2024] [Indexed: 04/12/2024] Open
Abstract
In continuous pharmaceutical manufacturing processes, it is crucial to control the powder flow rate. The feeding process is characterized by the amount of powder delivered per screw rotation, referred to as the feed factor. This study aims to develop models for predicting the feed factor profiles (FFPs) of two-component mixed powders with various formulations, while most previous studies have focused on single-component powders. It further aims to identify the suitable model type and to determine the significance of material properties in enhancing prediction accuracy by using several FFP prediction models with different input variables. Four datasets from the experiment were generated with different ranges of the mass fraction of active pharmaceutical ingredients (API) and the powder weight in the hopper. The candidates for the model inputs are (a) the mass fraction of API, (b) process parameters, and (c) material properties. It is desirable to construct a high-performance prediction model without the material properties because their measurement is laborious. The results show that using (c) as input variables did not improve the prediction accuracy as much, thus there is no need to use them.
Collapse
Affiliation(s)
- Yuki Kobayashi
- Department of Systems Science, Kyoto University, Yoshida-honmachi, Sakyo-ku, Kyoto 6068501, Kyoto, Japan
| | - Sanghong Kim
- Department of Applied Physics and Chemical Engineering, Tokyo University of Agriculture and Technology, 2-24-16 Naka-cho, Koganei, 1840012 Tokyo, Japan
| | - Takuya Nagato
- Research and Development Division, Powrex Corporation, 5-5-5 Kitagawara, Itami 6640837, Hyogo, Japan
| | - Takuya Oishi
- Research and Development Division, Powrex Corporation, 5-5-5 Kitagawara, Itami 6640837, Hyogo, Japan
- Department of Applied Chemistry, Tokyo University of Agriculture and Technology, 2-24-16 Naka-cho, Koganei, 1840012 Tokyo, Japan
| | - Manabu Kano
- Department of Systems Science, Kyoto University, Yoshida-honmachi, Sakyo-ku, Kyoto 6068501, Kyoto, Japan
| |
Collapse
|
5
|
Bhalode P, Razavi SM, Tian H, Roman-Ospino A, Scicolone J, Callegari G, Dubey A, Koolivand A, Krull S, O'Connor T, Muzzio FJ, Ierapetritou MG. Statistical data treatment for residence time distribution studies in pharmaceutical manufacturing. Int J Pharm 2024; 657:124133. [PMID: 38642620 DOI: 10.1016/j.ijpharm.2024.124133] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/18/2024] [Revised: 04/13/2024] [Accepted: 04/15/2024] [Indexed: 04/22/2024]
Abstract
Residence time distribution (RTD) method has been widely used in the pharmaceutical manufacturing for understanding powder dynamics within unit operations and continuous integrated manufacturing lines. The dynamics thus captured is then used to develop predictive models for unit operations and important RTD-based applications ensuring product quality assurance. Despite thorough efforts in tracer selection, data acquisition, and calibration model development to obtain tracer concentration profiles for RTD studies, there can exist significant noise in these profiles. This noise can make it challenging to identify the underlying signal and get a representative RTD of the system under study. Such concerns have previously indicated the importance of noise handling for RTD measurements in literature. However, the literature does not provide sufficient information on noise handling or data treatment strategies for RTD studies. To this end, we investigate the impact of varying levels of noise using different tracers on measurement of RTD profile and its applications. We quantify the impact of different denoising methods (time and frequency averaging methods). Through this investigation, we see that Savitsky Golay filtering turns out to a good method for denoising RTD profiles despite varying noise levels. The investigation is performed such that the key features of the RTD profile (which are important for RTD based applications) are preserved. Subsequently, we also investigate the impact of denoising on RTD-based applications such as out-of-specification (OOS) analysis and RTD modeling. The results show that the degree of noise levels considered in this work do not significantly impact the RTD-based applications.
Collapse
Affiliation(s)
- Pooja Bhalode
- Center of Plastics Innovation, University of Delaware, DE, USA
| | - Sonia M Razavi
- Department of Chemical and Biochemical Engineering, Rutgers University, NJ, USA
| | - Huayu Tian
- Department of Chemical and Biomolecular Engineering, University of Delaware, DE, USA
| | - Andres Roman-Ospino
- Department of Chemical and Biochemical Engineering, Rutgers University, NJ, USA
| | - James Scicolone
- Department of Chemical and Biochemical Engineering, Rutgers University, NJ, USA
| | - Gerardo Callegari
- Department of Chemical and Biochemical Engineering, Rutgers University, NJ, USA
| | - Atul Dubey
- Pharmaceutical Continuous Manufacturing (PCM), United States Pharmacopeia, 12601 Twinbrook Parkway, Rockville, MD, USA
| | - Abdollah Koolivand
- Office of Pharmaceutical Quality, Center for Drug Evaluation Research, Food and Drug Administration, 10903 New Hampshire Ave, Silver Springs, MD 20993, USA
| | - Scott Krull
- Office of Pharmaceutical Quality, Center for Drug Evaluation Research, Food and Drug Administration, 10903 New Hampshire Ave, Silver Springs, MD 20993, USA
| | - Thomas O'Connor
- Office of Pharmaceutical Quality, Center for Drug Evaluation Research, Food and Drug Administration, 10903 New Hampshire Ave, Silver Springs, MD 20993, USA
| | - Fernando J Muzzio
- Department of Chemical and Biochemical Engineering, Rutgers University, NJ, USA
| | | |
Collapse
|
6
|
Hur I, Casas-Orozco D, Laky D, Destro F, Nagy ZK. Digital design of an integrated purification system for continuous pharmaceutical manufacturing. Chem Eng Sci 2024; 285:119534. [PMID: 38975615 PMCID: PMC11225065 DOI: 10.1016/j.ces.2023.119534] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 07/09/2024]
Abstract
In this work dynamic models of the continuous crystallization, filtration, deliquoring, washing, and drying steps are introduced, which are developed in the open-source pharmaceutical modeling tool PharmaPy. These models enable the simulation and digital design of an integrated continuous two-stage crystallization and filtration-drying carousel system. The carousel offers an intensified process that can manufacture products with tailored properties through optimal design and control. Results show that improved crystallization design enhances overall process efficiency by improving critical material attributes of the crystal slurry for downstream filtration and drying operations. The digital design of the integrated process achieves enhanced productivity while satisfying multiple design and product quality constraints. Additionally, the impact of model uncertainty on the optimal operating conditions is investigated. The findings demonstrate the systematic process development potential of PharmaPy, providing improved process understanding, design space identification, and optimized robust operation.
Collapse
Affiliation(s)
- Inyoung Hur
- Davidson School of Chemical Engineering, Purdue University, West Lafayette, IN 4797 USA
| | - Daniel Casas-Orozco
- Davidson School of Chemical Engineering, Purdue University, West Lafayette, IN 4797 USA
| | - Daniel Laky
- Davidson School of Chemical Engineering, Purdue University, West Lafayette, IN 4797 USA
| | - Francesco Destro
- Davidson School of Chemical Engineering, Purdue University, West Lafayette, IN 4797 USA
- Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139
| | - Zoltan K. Nagy
- Davidson School of Chemical Engineering, Purdue University, West Lafayette, IN 4797 USA
| |
Collapse
|
7
|
Geremia M, Bezzo F, Ierapetritou MG. Design space determination of pharmaceutical processes: Effects of control strategies and uncertainty. Eur J Pharm Biopharm 2024; 194:159-169. [PMID: 38110160 DOI: 10.1016/j.ejpb.2023.12.008] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/16/2023] [Revised: 12/13/2023] [Accepted: 12/15/2023] [Indexed: 12/20/2023]
Abstract
The identification of process Design Space (DS) is of high interest in highly regulated industrial sectors, such as pharmaceutical industry, where assurance of manufacturability and product quality is key for process development and decision-making. If the process can be controlled by a set of manipulated variables, the DS can be expanded in comparison to an open-loop scenario, where there are no controls in place. Determining the benefits of control strategies may be challenging, particularly when the available model is complex and computationally expensive - which is typically the case of pharmaceutical manufacturing. In this study, we exploit surrogate-based feasibility analysis to determine whether the process satisfies all process constraints by manipulating the process inputs and reduce the effect of uncertainty. The proposed approach is successfully tested on two simulated pharmaceutical case studies of increasing complexity, i.e., considering (i) a single pharmaceutical unit operation, and (ii) a pharmaceutical manufacturing line comprised of a sequence of connected unit operations. Results demonstrate that different control actions can be effectively exploited to operate the process in a wider range of inputs and mitigate uncertainty.
Collapse
Affiliation(s)
- Margherita Geremia
- CAPE-Lab - Computer-Aided Process Engineering Laboratory, Department of Industrial Engineering, University of Padova, Via Marzolo 9, 35131 Padova, PD, Italy
| | - Fabrizio Bezzo
- CAPE-Lab - Computer-Aided Process Engineering Laboratory, Department of Industrial Engineering, University of Padova, Via Marzolo 9, 35131 Padova, PD, Italy
| | | |
Collapse
|
8
|
Matsunami K, Vandeputte T, Barrera Jiménez AA, Peeters M, Ghijs M, Van Hauwermeiren D, Stauffer F, Dos Santos Schultz E, Nopens I, De Beer T. Validation of model-based design of experiments for continuous wet granulation and drying. Int J Pharm 2023; 646:123493. [PMID: 37813175 DOI: 10.1016/j.ijpharm.2023.123493] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/07/2023] [Revised: 09/27/2023] [Accepted: 10/05/2023] [Indexed: 10/11/2023]
Abstract
This paper presents an application case of model-based design of experiments for the continuous twin-screw wet granulation and fluid-bed drying sequence. The proposed framework consists of three previously developed models. Here, we are testing the applicability of previously published unit operation models in this specific part of the production line to a new active pharmaceutical ingredient. Firstly, a T-shaped partial least squares regression model predicts d-values of granules after wet granulation with different process settings. Then, a high-resolution full granule size distribution is computed by a hybrid population balance and partial least squares regression model. Lastly, a mechanistic model of fluid-bed drying simulates drying time and energy efficiency, using the outputs of the first two models as a part of the inputs. In the application case, good operating conditions were calculated based on material and formulation properties as well as the developed process models. The framework was validated by comparing the simulation results with three experimental results. Overall, the proposed framework enables a process designer to find appropriate process settings with a less experimental workload. The framework combined with process knowledge reduced 73.2% of material consumption and 72.3% of time, especially in the early process development phase.
Collapse
Affiliation(s)
- Kensaku Matsunami
- Laboratory of Pharmaceutical Process Analytical Technology, Department of Pharmaceutical Analysis, Ghent University, Ottergemsesteenweg 460, Ghent, 9000, Oost-Vlaanderen, Belgium; BIOMATH, Department of Data Analysis and Mathematical Modelling, Ghent University, Coupure links 653, Ghent, 9000, Oost-Vlaanderen, Belgium.
| | - Tuur Vandeputte
- Laboratory of Pharmaceutical Process Analytical Technology, Department of Pharmaceutical Analysis, Ghent University, Ottergemsesteenweg 460, Ghent, 9000, Oost-Vlaanderen, Belgium; BIOMATH, Department of Data Analysis and Mathematical Modelling, Ghent University, Coupure links 653, Ghent, 9000, Oost-Vlaanderen, Belgium
| | - Ana Alejandra Barrera Jiménez
- Laboratory of Pharmaceutical Process Analytical Technology, Department of Pharmaceutical Analysis, Ghent University, Ottergemsesteenweg 460, Ghent, 9000, Oost-Vlaanderen, Belgium; BIOMATH, Department of Data Analysis and Mathematical Modelling, Ghent University, Coupure links 653, Ghent, 9000, Oost-Vlaanderen, Belgium
| | - Michiel Peeters
- Laboratory of Pharmaceutical Process Analytical Technology, Department of Pharmaceutical Analysis, Ghent University, Ottergemsesteenweg 460, Ghent, 9000, Oost-Vlaanderen, Belgium
| | - Michael Ghijs
- Laboratory of Pharmaceutical Process Analytical Technology, Department of Pharmaceutical Analysis, Ghent University, Ottergemsesteenweg 460, Ghent, 9000, Oost-Vlaanderen, Belgium; BIOMATH, Department of Data Analysis and Mathematical Modelling, Ghent University, Coupure links 653, Ghent, 9000, Oost-Vlaanderen, Belgium
| | - Daan Van Hauwermeiren
- Laboratory of Pharmaceutical Process Analytical Technology, Department of Pharmaceutical Analysis, Ghent University, Ottergemsesteenweg 460, Ghent, 9000, Oost-Vlaanderen, Belgium; BIOMATH, Department of Data Analysis and Mathematical Modelling, Ghent University, Coupure links 653, Ghent, 9000, Oost-Vlaanderen, Belgium
| | - Fanny Stauffer
- Product Design & Performance, UCB, Braine l'Alleud, 1420, Belgium
| | | | - Ingmar Nopens
- BIOMATH, Department of Data Analysis and Mathematical Modelling, Ghent University, Coupure links 653, Ghent, 9000, Oost-Vlaanderen, Belgium
| | - Thomas De Beer
- Laboratory of Pharmaceutical Process Analytical Technology, Department of Pharmaceutical Analysis, Ghent University, Ottergemsesteenweg 460, Ghent, 9000, Oost-Vlaanderen, Belgium
| |
Collapse
|
9
|
Tanabe S, Muraki T, Yaginuma K, Kim S, Kano M. Greedy design space construction based on regression and latent space extraction for pharmaceutical development. Int J Pharm 2023; 642:123178. [PMID: 37364782 DOI: 10.1016/j.ijpharm.2023.123178] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/15/2023] [Revised: 05/23/2023] [Accepted: 06/22/2023] [Indexed: 06/28/2023]
Abstract
Implementation of the design space (DS) is a scientific concept for ensuring quality to be submitted as a part of the regulatory filing of a drug product for approval to market. An empirical approach is constructing the DS based on the regression model whose inputs are process parameters and material attributes over the different unit operations, i.e., a high-dimensional statistical model. While the high-dimensional model assures quality and process flexibility through a comprehensive process understanding, it has difficulty visualizing the feasible range of input parameters, i.e., DS. Therefore, this study proposes a greedy approach to constructing the extensive and flexible low-dimensional DS based on the high-dimensional statistical model and the observed internal representations that satisfies both comprehensive process understanding and the DS visualization capability. Introducing the observed correlation structure enabled the dimensionality reduction of the DS. The non-critical controllable parameters were fixed to the target values in visualizing the low-dimensional DS as a function of critical parameters. The expected variation of non-critical non-controllable parameters was considered the source of variation in prediction. The case study demonstrated the proposed approach's usefulness for developing the pharmaceutical manufacturing process.
Collapse
Affiliation(s)
- Shuichi Tanabe
- Formulation Technology Research Laboratories, Daiichi Sankyo Co., Ltd., 1-12-1 Shinomiya, 2540014 Hiratsuka, Japan.
| | - Tatsuya Muraki
- Department of Systems Science, Kyoto University, Yoshida-honmachi, Sakyo-ku, Kyoto 6068501, Japan
| | - Keita Yaginuma
- Formulation Technology Research Laboratories, Daiichi Sankyo Co., Ltd., 1-12-1 Shinomiya, 2540014 Hiratsuka, Japan
| | - Sanghong Kim
- Department of Applied Physics and Chemical Engineering, Tokyo University of Agriculture and Technology, 2-24-16 Naka-cho, Koganei 1840012, Japan
| | - Manabu Kano
- Department of Systems Science, Kyoto University, Yoshida-honmachi, Sakyo-ku, Kyoto 6068501, Japan
| |
Collapse
|
10
|
Jones-Salkey O, Chu Z, Ingram A, Windows-Yule CRK. Reviewing the Impact of Powder Cohesion on Continuous Direct Compression (CDC) Performance. Pharmaceutics 2023; 15:1587. [PMID: 37376036 DOI: 10.3390/pharmaceutics15061587] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/03/2023] [Revised: 05/08/2023] [Accepted: 05/10/2023] [Indexed: 06/29/2023] Open
Abstract
The pharmaceutical industry is undergoing a paradigm shift towards continuous processing from batch, where continuous direct compression (CDC) is considered to offer the most straightforward implementation amongst powder processes due to the relatively low number of unit operations or handling steps. Due to the nature of continuous processing, the bulk properties of the formulation will require sufficient flowability and tabletability in order to be processed and transported effectively to and from each unit operation. Powder cohesion presents one of the greatest obstacles to the CDC process as it inhibits powder flow. As a result, there have been many studies investigating potential manners in which to overcome the effects of cohesion with, to date, little consideration of how these controls may affect downstream unit operations. The aim of this literature review is to explore and consolidate this literature, considering the impact of powder cohesion and cohesion control measures on the three-unit operations of the CDC process (feeding, mixing, and tabletting). This review will also cover the consequences of implementing such control measures whilst highlighting subject matter which could be of value for future research to better understand how to manage cohesive powders for CDC manufacture.
Collapse
Affiliation(s)
- Owen Jones-Salkey
- Oral Product Development, Pharmaceutical Technology & Development, Operations, AstraZeneca, Macclesfield SK10 2NA, UK
- School of Chemical Engineering, University of Birmingham, Birmingham B15 2TT, UK
| | - Zoe Chu
- Oral Product Development, Pharmaceutical Technology & Development, Operations, AstraZeneca, Macclesfield SK10 2NA, UK
- School of Chemical Engineering, University of Birmingham, Birmingham B15 2TT, UK
| | - Andrew Ingram
- School of Chemical Engineering, University of Birmingham, Birmingham B15 2TT, UK
| | | |
Collapse
|
11
|
Rosas JG, Brush P, Thompson B, Miller C, Overton P, Tugby N, Stoliarskaia D, Hurley S, Ramasamy M, Conway SL. Implementation of a fully integrated CM direct compression and coating process at a commercial pharmaceutical facility - Part 2: PAT and RTD results for normal operational conditions batches. Int J Pharm 2023; 636:122814. [PMID: 36918116 DOI: 10.1016/j.ijpharm.2023.122814] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/29/2022] [Revised: 03/02/2023] [Accepted: 03/05/2023] [Indexed: 03/13/2023]
Abstract
This is the second of two articles detailing the continuous manufacturing (CM) development and implementation activities for an marketed product which have been realized in novel, qualified equipment, using validated control strategy elements to enable manufacture of batches under current good manufacturing practices (cGMP) and compliant with data integrity principles. Here, the application of process analytical technologies (PAT) and automation tools on batches produced under normal operational conditions is reviewed. The results from residence time distribution (RTD) models for predicting API concentration, in-line near infrared (NIR) testing of blend uniformity (BU) and at-line NIR spectroscopy analysis of core tablet concentration and tablet identity for real-time release testing (RTRT) are discussed. The influences of process equipment and design choices on NIR and RTD model variability, as well as the use of the PAT tools for monitoring the evolving properties understanding of CM process development, such as overcoming flow instabilities, is described. Results demonstrate that the RTD and NIR models developed and validated are robust to operating conditions and are critical for assuring steady state control of the continuous manufacturing process. Finally, the NIR and RTD model lifecycle, including procedures for necessary and normal model upgrades in a cGMP production environment, are presented.
Collapse
Affiliation(s)
- Juan G Rosas
- MSD, Pharmaceutical Technical Operations PAT, UK.
| | - Peter Brush
- Merck & Co. Inc, Analytical Chemistry in Development and Supply PAT, United States
| | - Bruce Thompson
- Merck & Co. Inc, Analytical Chemistry in Development and Supply PAT, United States
| | - Charles Miller
- Merck & Co. Inc, Analytical Chemistry in Development and Supply PAT, United States
| | | | - Neil Tugby
- MSD, Pharmaceutical Technical Operations, UK
| | | | - Samantha Hurley
- Merck & Co. Inc, Pharmaceutical Commercialization Technology, United States
| | - Manoharan Ramasamy
- Merck & Co. Inc, Analytical Chemistry in Development and Supply PAT, United States
| | | |
Collapse
|
12
|
Matsunami K, Miura T, Yaginuma K, Tanabe S, Badr S, Sugiyama H. Surrogate modeling of dissolution behavior toward efficient design of tablet manufacturing processes. Comput Chem Eng 2023. [DOI: 10.1016/j.compchemeng.2023.108141] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/18/2023]
|
13
|
Bekaert B, Van Snick B, Pandelaere K, Dhondt J, Di Pretoro G, De Beer T, Vervaet C, Vanhoorne V. Continuous direct compression: Development of an empirical predictive model and challenges regarding PAT implementation. Int J Pharm X 2022; 4:100110. [PMID: 35024605 PMCID: PMC8732775 DOI: 10.1016/j.ijpx.2021.100110] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/30/2021] [Revised: 12/21/2021] [Accepted: 12/23/2021] [Indexed: 11/21/2022] Open
Abstract
In this study, an empirical predictive model was developed based on the quantitative relationships between blend properties, critical quality attributes (CQA) and critical process parameters (CPP) related to blending and tableting. The blend uniformity and API concentration in the tablets were used to elucidate challenges related to the processability as well as the implementation of PAT tools. Thirty divergent ternary blends were evaluated on a continuous direct compression line (ConsiGma™ CDC-50). The trials showed a significant impact of the impeller configuration and impeller speed on the blending performance, whereas a limited impact of blend properties was observed. In contrast, blend properties played a significant role during compression, where changes in blend composition significantly altered the tablet quality. The observed correlations allowed to develop an empirical predictive model for the selection of process configurations based on the blend properties, reducing the number of trial runs needed to optimize a process and thus reducing development time and costs of new drug products. Furthermore, the trials elucidated several challenges related to blend properties that had a significant impact on PAT implementation and performance of the CDC-platform, highlighting the importance of further process development and optimization in order to solve the remaining challenges.
Collapse
Key Words
- #BP, Number of blade passes
- #RMB1, Number of radial mixing blades of the main blender
- API, Active pharmaceutical ingredient
- API_sd, Spray dried API
- BRT, Bulk residence time
- BU, Blend uniformity
- CDC, Continuous direct compression
- CDC-50
- CU, Content uniformity
- C_P, Caffeine anhydrous powder
- Continuous direct compression
- Continuous manufacturing
- DCP, Dicalcium phosphate / Emcompress AN
- FD, Fill depth
- HM1/HM2, Hold-up mass main blender/Hold-up mass lubricant blender
- Imp1, Impeller speed main blender
- LC, Percentage label claim
- MCF, Main compression force
- MCH, Main compression height
- MPT_μ, Metoprolol micronized
- MgSt, Magnesium stearate/Ligamed MF-2-V
- Multivariate data-analysis
- NIR, Near infrared
- PAT
- PAT, Process Analytical Technology
- PC, Principle component
- PCA, Principle component analysis
- PCD, Pre-compression displacement
- PCF, Pre-compression force
- PCH, Pre-compression height
- PH101, Microcrystalline cellulose / Avicel PH-101
- PH200, Microcrystalline cellulose / Avicel PH-200
- PLS, Partial least squares
- P_DP, Paracetamol dense powder
- P_P, Paracetamol powder
- P_μ, Paracetamol micronized
- Predictive modeling
- Q2, Goodness of prediction
- R2Y, Goodness of fit
- RMSEcv, Root mean squared error of cross validation
- RSDTW, Relative standard deviation of tablet weight
- SD100, Mannitol / Pearlitol 100 SD
- T80, Lactose / Tablettose 80
- T_P, Theophylline anhydrous powder
- rpm, Revolutions per minute
- σForce, Main compression force variability
- σPCD, Variability in pre-compression displacement
Collapse
Affiliation(s)
- B. Bekaert
- Laboratory of Pharmaceutical Technology, Department of Pharmaceutics, Ghent University, Ottergemsesteenweg 460, B-9000 Ghent, Belgium
| | - B. Van Snick
- Oral Solid Dosage, Drug Product Development, Discovery Product Development and Supplies, Pharmaceutical Research and Development, Division of Janssen Pharmaceutica, Johnson & Johnson, Turnhoutseweg 30, B-2340 Beerse, Belgium
| | - K. Pandelaere
- Laboratory of Pharmaceutical Technology, Department of Pharmaceutics, Ghent University, Ottergemsesteenweg 460, B-9000 Ghent, Belgium
| | - J. Dhondt
- Oral Solid Dosage, Drug Product Development, Discovery Product Development and Supplies, Pharmaceutical Research and Development, Division of Janssen Pharmaceutica, Johnson & Johnson, Turnhoutseweg 30, B-2340 Beerse, Belgium
| | - G. Di Pretoro
- Oral Solid Dosage, Drug Product Development, Discovery Product Development and Supplies, Pharmaceutical Research and Development, Division of Janssen Pharmaceutica, Johnson & Johnson, Turnhoutseweg 30, B-2340 Beerse, Belgium
| | - T. De Beer
- Laboratory of Pharmaceutical Process Analytical Technology, Department of Pharmaceutical Analysis, Ghent University, Ottergemsesteenweg 460, B-9000 Ghent, Belgium
| | - C. Vervaet
- Laboratory of Pharmaceutical Technology, Department of Pharmaceutics, Ghent University, Ottergemsesteenweg 460, B-9000 Ghent, Belgium
| | - V. Vanhoorne
- Laboratory of Pharmaceutical Technology, Department of Pharmaceutics, Ghent University, Ottergemsesteenweg 460, B-9000 Ghent, Belgium
| |
Collapse
|
14
|
Digital twin of a continuous direct compression line for drug product and process design using a hybrid flowsheet modelling approach. Int J Pharm 2022; 628:122336. [DOI: 10.1016/j.ijpharm.2022.122336] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/13/2022] [Revised: 10/19/2022] [Accepted: 10/20/2022] [Indexed: 11/06/2022]
|
15
|
Tian H, Bhalode P, Razavi SM, Koolivand A, Muzzio FJ, Ierapetritou MG. Characterization and propagation of RTD uncertainty for continuous powder blending processes. Int J Pharm 2022; 628:122326. [DOI: 10.1016/j.ijpharm.2022.122326] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/15/2022] [Revised: 09/18/2022] [Accepted: 10/16/2022] [Indexed: 10/31/2022]
|
16
|
Ge Wang L, Omar C, Litster J, Slade D, Li J, Salman A, Bellinghausen S, Barrasso D, Mitchell N. Model Driven Design for Integrated Twin Screw Granulator and Fluid Bed Dryer via Flowsheet Modelling. Int J Pharm 2022; 628:122186. [PMID: 36130681 DOI: 10.1016/j.ijpharm.2022.122186] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/07/2022] [Revised: 09/02/2022] [Accepted: 09/03/2022] [Indexed: 11/27/2022]
Abstract
This paper presents a flowsheet modelling of an integrated twin screw granulation (TSG) and fluid bed dryer (FBD) process using a Model Driven Design (MDD) approach. The MDD approach is featured by appropriate process models and efficient model calibration workflow to ensure the product quality. The design space exploration is driven by the physics of the process instead of extensive experimental trials. By means of MDD, the mechanistic-based process kernels are first defined for the TSG and FBD processes. With the awareness of the underlying physics, the complementary experiments are carried out with relevance to the kinetic parameters in the defined models. As a result, the experiments are specifically purposeful for model calibration and validation. The L/S ratio (liquid to solid ratio) and inlet air temperature are selected as the Critical Process Parameters (CPPs) in TSG and FBD for model validation, respectively. Global System Analysis (GSA) is further performed to assess the uncertainty of CPPs imposed on the Critical Quality Attributes (CQAs), which provides significant insights to the exploration of the design space considering both TSG and FBD process parameters.
Collapse
Affiliation(s)
- Li Ge Wang
- Siemens Process Systems Engineering, Hammersmith, London, UK; Department of Chemical and Biological Engineering, University of Sheffield, UK
| | - Chalak Omar
- Department of Chemical and Biological Engineering, University of Sheffield, UK
| | - James Litster
- Department of Chemical and Biological Engineering, University of Sheffield, UK.
| | - David Slade
- Siemens Process Systems Engineering, Hammersmith, London, UK
| | - Jianfeng Li
- Siemens Process Systems Engineering, Parsippany, New Jersey, USA
| | - Agba Salman
- Department of Chemical and Biological Engineering, University of Sheffield, UK
| | | | - Dana Barrasso
- Siemens Process Systems Engineering, Hammersmith, London, UK
| | - Niall Mitchell
- Siemens Process Systems Engineering, Hammersmith, London, UK
| |
Collapse
|
17
|
Jelsch M, Roggo Y, Mohamad A, Kleinebudde P, Krumme M. Automatic system dynamics characterization of a pharmaceutical continuous production line. Eur J Pharm Biopharm 2022; 180:137-148. [PMID: 36122784 DOI: 10.1016/j.ejpb.2022.09.010] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/20/2022] [Revised: 09/09/2022] [Accepted: 09/12/2022] [Indexed: 11/04/2022]
Abstract
Continuous Manufacturing (CM) of drug products is a new approach in the pharmaceutical industry. In the presented paper, a GMP continuous wet granulation line for production of solid oral dosage forms was investigated in order to assess the system dynamics of the line and to define the best control and diversion strategy. The following steps were involved in the continuous process: dosing / feeding, blending, twin-screw wet granulation, fluid-bed drying, sieving and tableting. Two drug products with two different drug substances were compared during this study: one drug substance as model drug compound and one formulation of a currently evaluated commercial drug product. Several step tests in API concentration were performed in order to characterize the process flow and assess the process dynamics. API content was monitored in real time by Process Analytical Technologies (PAT) thanks to three Near Infrared (NIR) probes located along the process and measuring the API content after blender, after dryer and in the tablet press feed frame. The process parameter values were changed during production in order to detect the impact on the quality of the final product. An automatic residence time distribution (RTD) computation method has been developed in order automate the RTD calculation on the basis of process data to further define and monitor the system dynamics with the final aim of out of specification material diversion during the continuous production. The RTD has been seen as a process fingerprint: a change in the RTD values implies a change in the process.
Collapse
Affiliation(s)
- Morgane Jelsch
- Novartis Pharma AG, Continuous Manufacturing (CM) Unit, CH-4002 Basel, Switzerland
| | - Yves Roggo
- Novartis Pharma AG, Continuous Manufacturing (CM) Unit, CH-4002 Basel, Switzerland
| | - Ahmad Mohamad
- Novartis Pharma AG, Continuous Manufacturing (CM) Unit, CH-4002 Basel, Switzerland
| | - Peter Kleinebudde
- Heinrich Heine University, Universitätsstraße1, 40225 Düsseldorf, Germany
| | - Markus Krumme
- Novartis Pharma AG, Continuous Manufacturing (CM) Unit, CH-4002 Basel, Switzerland.
| |
Collapse
|
18
|
Zhong L, Gao L, Li L, Nie L, Zhang H, Sun Z, Huang R, Zhou Z, Yin W, Wang H, Zang H. Implementation of Dynamic and Static Moisture Control in Fluidized Bed Granulation. AAPS PharmSciTech 2022; 23:174. [PMID: 35739377 DOI: 10.1208/s12249-022-02334-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/26/2022] [Accepted: 06/14/2022] [Indexed: 11/30/2022] Open
Abstract
The application of process analysis and control is essential to enhance process understanding and ensure output material quality. The present study focuses on the stability of the feedback control system for a fluidized bed granulation process. Two strategies of dynamic moisture control (DMC) and static moisture control (SMC) were established based on the in-line moisture value obtained from the near-infrared sensor and control algorithm. The performance of these strategies on quality consistency control was examined using process moisture similarity analysis and principal component analysis. The stable moisture control performance and low batch-to-batch variability indicated that the DMC method was significantly better than other granulation methods. In addition, the investigation of robustness further showed that the implemented DMC method was able to produce predetermined target moisture values by varying process parameters. This study provides an advanced and simple control method for fluidized bed granulation quality assurance.
Collapse
Affiliation(s)
- Liang Zhong
- NMPA Key Laboratory for Technology Research and Evaluation of Drug Products, School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, 250012, Shandong, China
| | - Lele Gao
- NMPA Key Laboratory for Technology Research and Evaluation of Drug Products, School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, 250012, Shandong, China
| | - Lian Li
- NMPA Key Laboratory for Technology Research and Evaluation of Drug Products, School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, 250012, Shandong, China
| | - Lei Nie
- NMPA Key Laboratory for Technology Research and Evaluation of Drug Products, School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, 250012, Shandong, China
| | - Hui Zhang
- NMPA Key Laboratory for Technology Research and Evaluation of Drug Products, School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, 250012, Shandong, China
| | - Zhongyu Sun
- NMPA Key Laboratory for Technology Research and Evaluation of Drug Products, School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, 250012, Shandong, China
| | - Ruiqi Huang
- NMPA Key Laboratory for Technology Research and Evaluation of Drug Products, School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, 250012, Shandong, China
| | - Zhaobang Zhou
- NMPA Key Laboratory for Technology Research and Evaluation of Drug Products, School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, 250012, Shandong, China
| | - Wenping Yin
- Shandong SMA Pharmatech Co., Ltd, 165, Huabei Rd., High & New Technology Zone Zibo, Shandong, 0533, China
| | - Hui Wang
- Shandong SMA Pharmatech Co., Ltd, 165, Huabei Rd., High & New Technology Zone Zibo, Shandong, 0533, China
| | - Hengchang Zang
- NMPA Key Laboratory for Technology Research and Evaluation of Drug Products, School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, 250012, Shandong, China. .,National Glycoengineering Research Center, Shandong University, Jinan, 250012, Shandong, China. .,Key Laboratory of Chemical Biology (Ministry of Education), Shandong University, Jinan, 250012, China.
| |
Collapse
|
19
|
Singh M, Shirazian S, Ranade V, Walker GM, Kumar A. Challenges and opportunities in modelling wet granulation in pharmaceutical industry – A critical review. POWDER TECHNOL 2022. [DOI: 10.1016/j.powtec.2022.117380] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/15/2022]
|
20
|
Johnson BJ, Sen M, Hanson J, García-Muñoz S, Sahinidis NV. Stochastic analysis and modeling of pharmaceutical screw feeder mass flow rates. Int J Pharm 2022; 621:121776. [DOI: 10.1016/j.ijpharm.2022.121776] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/20/2021] [Revised: 04/16/2022] [Accepted: 04/24/2022] [Indexed: 11/27/2022]
|
21
|
Destro F, Barolo M. A review on the modernization of pharmaceutical development and manufacturing - Trends, perspectives, and the role of mathematical modeling. Int J Pharm 2022; 620:121715. [PMID: 35367580 DOI: 10.1016/j.ijpharm.2022.121715] [Citation(s) in RCA: 15] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/19/2022] [Revised: 03/23/2022] [Accepted: 03/29/2022] [Indexed: 01/20/2023]
Abstract
Recently, the pharmaceutical industry has been facing several challenges associated to the use of outdated development and manufacturing technologies. The return on investment on research and development has been shrinking, and, at the same time, an alarming number of shortages and recalls for quality concerns has been registered. The pharmaceutical industry has been responding to these issues through a technological modernization of development and manufacturing, under the support of initiatives and activities such as quality-by-design (QbD), process analytical technology, and pharmaceutical emerging technology. In this review, we analyze this modernization trend, with emphasis on the role that mathematical modeling plays within it. We begin by outlining the main socio-economic trends of the pharmaceutical industry, and by highlighting the life-cycle stages of a pharmaceutical product in which technological modernization can help both achieve consistently high product quality and increase return on investment. Then, we review the historical evolution of the pharmaceutical regulatory framework, and we discuss the current state of implementation and future trends of QbD. The pharmaceutical emerging technology is reviewed afterwards, and a discussion on the evolution of QbD into the more effective quality-by-control (QbC) paradigm is presented. Further, we illustrate how mathematical modeling can support the implementation of QbD and QbC across all stages of the pharmaceutical life-cycle. In this respect, we review academic and industrial applications demonstrating the impact of mathematical modeling on three key activities within pharmaceutical development and manufacturing, namely design space description, process monitoring, and active process control. Finally, we discuss some future research opportunities on the use of mathematical modeling in industrial pharmaceutical environments.
Collapse
Affiliation(s)
- Francesco Destro
- CAPE-Lab - Computer-Aided Process Engineering Laboratory, Department of Industrial Engineering, University of Padova, via Marzolo 9, 35131 Padova PD, Italy
| | - Massimiliano Barolo
- CAPE-Lab - Computer-Aided Process Engineering Laboratory, Department of Industrial Engineering, University of Padova, via Marzolo 9, 35131 Padova PD, Italy.
| |
Collapse
|
22
|
Hernández B, Pinto MA, Martín M. Generation of a surrogate compartment model for counter-current spray dryer. Fluxes and momentum modeling. Comput Chem Eng 2022. [DOI: 10.1016/j.compchemeng.2022.107664] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
23
|
Hurley S, Tantuccio A, Escotet-Espinoza MS, Flamm M, Metzger M. Development and Use of a Residence Time Distribution (RTD) Model Control Strategy for a Continuous Manufacturing Drug Product Pharmaceutical Process. Pharmaceutics 2022; 14:355. [PMID: 35214087 PMCID: PMC8874656 DOI: 10.3390/pharmaceutics14020355] [Citation(s) in RCA: 6] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/15/2021] [Revised: 01/26/2022] [Accepted: 01/28/2022] [Indexed: 01/27/2023] Open
Abstract
Residence-time-distribution (RTD)-based models are key to understanding the mixing dynamics of continuous manufacturing systems. Such models can allow for material traceability throughout the process and can provide the ability for removal of non-conforming material from the finished product. These models have been implemented in continuous pharmaceutical manufacturing mainly for monitoring purposes, not as an integral part of the control strategy and in-process specifications. This paper discusses the steps taken to develop an RTD model design space and how the model was statistically incorporated into the product's control strategy. To develop the model, experiments were conducted at a range of blender impeller speeds and total system mass flow rates. RTD parameters were optimized for each condition tested using a tank-in-series-type model with a delay. Using the experimental RTD parameters, an equation was derived relating the mean residence time to the operating conditions (i.e., blender impeller speed and mass flow rate). The RTD parameters were used in combination with real-time upstream process data to predict downstream API concentration, where these predictions allowed validation across the entire operating range of the process by comparison to measured tablet assay. The standard in-process control limits for the product were statistically tightened using the validation acceptance criteria. Ultimately, this model and strategy were accepted by regulatory authorities.
Collapse
Affiliation(s)
- Samantha Hurley
- Pharmaceutical Commercialization Technology, Merck & Co., Inc., West Point, PA 19486, USA; (A.T.); (M.M.)
| | - Anthony Tantuccio
- Pharmaceutical Commercialization Technology, Merck & Co., Inc., West Point, PA 19486, USA; (A.T.); (M.M.)
| | | | - Matthew Flamm
- Applied Mathematics and Modeling, Merck & Co., Inc., West Point, PA 19486, USA;
| | - Matthew Metzger
- Pharmaceutical Commercialization Technology, Merck & Co., Inc., West Point, PA 19486, USA; (A.T.); (M.M.)
| |
Collapse
|
24
|
Bano G, Dhenge RM, Diab S, Goodwin DJ, Gorringe L, Ahmed M, Elkes R, Zomer S. Streamlining the development of an industrial dry granulation process for an immediate release tablet with systems modelling. Chem Eng Res Des 2022. [DOI: 10.1016/j.cherd.2021.12.033] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
25
|
Peterwitz M, Gerling S, Schembecker G. Challenges in tracing material flow passing a loss-in-weight feeder in continuous manufacturing processes. Int J Pharm 2022; 612:121304. [PMID: 34800615 DOI: 10.1016/j.ijpharm.2021.121304] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/08/2021] [Revised: 11/11/2021] [Accepted: 11/13/2021] [Indexed: 12/31/2022]
Abstract
Loss-in-weight feeders are an integral part of most continuous manufacturing processes, ensuring a constant mass flow. The feeders cause a significant degree of back-mixing in such lines. Understanding back-mixing is essential for the treatment of disturbances. However, feeders refilled semi-continuously contradict the common theory assuming steady-state. This study aims at understanding dynamic back-mixing and related phenomena. Low filling levels of a feeder are investigated using a fluorescent tracer. These investigations prove an impact of the addition of material probably caused by a non-uniform draw-in of the screws and dead material in the hopper. In turn, the dead material accounts for up to 50 % of the material in the hopper. Possible evidence of dead zones at higher filling levels and in feeders from literature are discussed additionally. Steady-state models from literature are extended to represent the observations and back-mixing at all filling levels. This extension reduces the root-mean-squared deviation of the model from the experimental data by 41%. The model predicts different responses to similar disturbances depending on the filling. This state-dependent back-mixing and the observed dead zones are challenging for diverting non-conforming material and material traceability. Therefore, these phenomena should be considered in selecting and operating feeders.
Collapse
Affiliation(s)
- Moritz Peterwitz
- Laboratory of Plant and Process Design, Faculty of Biochemical and Chemical Engineering, TU Dortmund University, Emil-Figge-Straße 70, D-44227 Dortmund, Germany; Invite GmbH, Otto-Bayer-Straße 32, D-51061 Cologne, Germany
| | - Sina Gerling
- Laboratory of Plant and Process Design, Faculty of Biochemical and Chemical Engineering, TU Dortmund University, Emil-Figge-Straße 70, D-44227 Dortmund, Germany
| | - Gerhard Schembecker
- Laboratory of Plant and Process Design, Faculty of Biochemical and Chemical Engineering, TU Dortmund University, Emil-Figge-Straße 70, D-44227 Dortmund, Germany.
| |
Collapse
|
26
|
Peterwitz M, Jodwirschat J, Loll R, Schembecker G. Tracking raw material flow through a continuous direct compression line Part I of II: Residence time distribution modeling and sensitivity analysis enabling increased process yield. Int J Pharm 2022; 614:121467. [PMID: 35032576 DOI: 10.1016/j.ijpharm.2022.121467] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/05/2021] [Revised: 12/30/2021] [Accepted: 01/08/2022] [Indexed: 11/30/2022]
Abstract
Continuous manufacturing (CM) offers advantages in quality and space-time yield compared to common batch manufacturing. However, higher yield losses due to the start-up procedure make a broad application uneconomical. This work discusses the possibility of reducing yield losses by adjusting the degree of back-mixing. Back-mixing of nonconforming material from disturbances or start-up will result in the contamination of subsequent material. Therefore, higher degrees of back-mixing cause the discharge of additional material. Choosing an advantageous setting of operational parameters may be a simple way to change the degree of back-mixing. Based on direct compression, this work demonstrates the identification of promising parameters. Therefore, step-change experiments using color-marked material in the feeder, blender, and tablet press quantify the impact of three operational parameters per device. Models for the devices and the entire process result from those measurements. Subsequently, a global variance-based sensitivity analysis identifies the most influential parameters. As a result, adjusting the minimal filling level of the feeder and the rotational feed frame speed of the tablet press reduces back-mixing by more than 30%. At high costs of the raw materials, the resulting savings can significantly improve the economic performance of CM compared to batch manufacturing.
Collapse
Affiliation(s)
- Moritz Peterwitz
- Laboratory of Plant and Process Design, Faculty of Biochemical and Chemical Engineering, TU Dortmund University, Emil-Figge-Straße 70, D-44227 Dortmund, Germany; Invite GmbH, Otto-Bayer-Straße 32, D-51061 Cologne, Germany
| | - Janis Jodwirschat
- Laboratory of Plant and Process Design, Faculty of Biochemical and Chemical Engineering, TU Dortmund University, Emil-Figge-Straße 70, D-44227 Dortmund, Germany
| | - Rouven Loll
- Laboratory of Plant and Process Design, Faculty of Biochemical and Chemical Engineering, TU Dortmund University, Emil-Figge-Straße 70, D-44227 Dortmund, Germany
| | - Gerhard Schembecker
- Laboratory of Plant and Process Design, Faculty of Biochemical and Chemical Engineering, TU Dortmund University, Emil-Figge-Straße 70, D-44227 Dortmund, Germany
| |
Collapse
|
27
|
Moritz P, Simon B, Meier R, Gerhard S. Tracking raw material flow through a continuous direct compression line. Part II of II: Predicting dynamic changes in quality attributes of tablets due to disturbances in raw material properties using an independent residence time distribution model. Int J Pharm 2022; 615:121528. [DOI: 10.1016/j.ijpharm.2022.121528] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/05/2021] [Revised: 01/23/2022] [Accepted: 01/26/2022] [Indexed: 10/19/2022]
|
28
|
Sacher S, Poms J, Rehrl J, Khinast JG. PAT implementation for advanced process control in solid dosage manufacturing - A practical guide. Int J Pharm 2021; 613:121408. [PMID: 34952147 DOI: 10.1016/j.ijpharm.2021.121408] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/04/2021] [Revised: 12/10/2021] [Accepted: 12/16/2021] [Indexed: 01/14/2023]
Abstract
The implementation of continuous pharmaceutical manufacturing requires advanced control strategies rather than traditional end product testing or an operation within a small range of controlled parameters. A high level of automation based on process models and hierarchical control concepts is desired. The relevant tools that have been developed and successfully tested in academic and industrial environments in recent years are now ready for utilization on the commercial scale. To date, the focus in Process Analytical Technology (PAT) has mainly been on achieving process understanding and quality control with the ultimate goal of real-time release testing (RTRT). This work describes the workflow for the development of an in-line monitoring strategy to support PAT-based real-time control actions and its integration into solid dosage manufacturing. All stages are discussed in this paper, from process analysis and definition of the monitoring task to technology assessment and selection, its process integration and the development of data acquisition.
Collapse
Affiliation(s)
- Stephan Sacher
- Research Center Pharmaceutical Engineering GmbH, Inffeldgasse 13/2, 8010 Graz, Austria.
| | - Johannes Poms
- Research Center Pharmaceutical Engineering GmbH, Inffeldgasse 13/2, 8010 Graz, Austria
| | - Jakob Rehrl
- Research Center Pharmaceutical Engineering GmbH, Inffeldgasse 13/2, 8010 Graz, Austria
| | - Johannes G Khinast
- Research Center Pharmaceutical Engineering GmbH, Inffeldgasse 13/2, 8010 Graz, Austria; Institute for Process and Particle Engineering, Graz University of Technology, Inffeldgasse 13/3, 8010 Graz, Austria
| |
Collapse
|
29
|
Bhalode P, Tian H, Gupta S, Razavi SM, Roman-Ospino A, Talebian S, Singh R, Scicolone JV, Muzzio FJ, Ierapetritou M. Using residence time distribution in pharmaceutical solid dose manufacturing - A critical review. Int J Pharm 2021; 610:121248. [PMID: 34748808 DOI: 10.1016/j.ijpharm.2021.121248] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/20/2021] [Revised: 10/04/2021] [Accepted: 10/27/2021] [Indexed: 11/18/2022]
Abstract
While continuous manufacturing (CM) of pharmaceutical solid-based drug products has been shown to be advantageous for improving the product quality and process efficiency in alignment with FDA's support of the quality-by-design paradigm (Lee, 2015; Ierapetritou et al., 2016; Plumb, 2005; Schaber, 2011), it is critical to enable full utilization of CM technology for robust production and commercialization (Schaber, 2011; Byrn, 2015). To do so, an important prerequisite is to obtain a detailed understanding of overall process characteristics to develop cost-effective and accurate predictive models for unit operations and process flowsheets. These models are utilized to predict product quality and maintain desired manufacturing efficiency (Ierapetritou et al., 2016). Residence time distribution (RTD) has been a widely used tool to characterize the extent of mixing in pharmaceutical unit operations (Vanhoorne, 2020; Rogers and Ierapetritou, 2015; Teżyk et al., 2015) and manufacturing lines and develop computationally cheap predictive models. These models developed using RTD have been demonstrated to be crucial for various flowsheet applications (Kruisz, 2017; Martinetz, 2018; Tian, 2021). Though extensively used in the literature (Gao et al., 2012), the implementation, execution, evaluation, and assessment of RTD studies has not been standardized by regulatory agencies and can thus lead to ambiguity regarding their accurate implementation. To address this issue and subsequently prevent unforeseen errors in RTD implementation, the presented article aims to aid in developing standardized guidelines through a detailed review and critical discussion of RTD studies in the pharmaceutical manufacturing literature. The review article is divided into two main sections - 1) determination of RTD including different steps for RTD evaluation including experimental approach, data acquisition and pre-treatment, RTD modeling, and RTD metrics and, 2) applications of RTD for solid dose manufacturing. Critical considerations, pertaining to the limitations of RTDs for solid dose manufacturing, are also examined along with a perspective discussion of future avenues of improvement.
Collapse
Affiliation(s)
- Pooja Bhalode
- Department of Chemical and Biochemical Engineering, Rutgers - The State University of New Jersey, Piscataway, NJ 08854, USA
| | - Huayu Tian
- Department of Chemical and Biomolecular Engineering, University of Delaware, Newark, DE 19716, USA
| | - Shashwat Gupta
- Department of Chemical and Biochemical Engineering, Rutgers - The State University of New Jersey, Piscataway, NJ 08854, USA
| | - Sonia M Razavi
- Department of Chemical and Biochemical Engineering, Rutgers - The State University of New Jersey, Piscataway, NJ 08854, USA
| | - Andres Roman-Ospino
- Department of Chemical and Biochemical Engineering, Rutgers - The State University of New Jersey, Piscataway, NJ 08854, USA
| | - Shahrzad Talebian
- Department of Chemical and Biochemical Engineering, Rutgers - The State University of New Jersey, Piscataway, NJ 08854, USA
| | - Ravendra Singh
- Department of Chemical and Biochemical Engineering, Rutgers - The State University of New Jersey, Piscataway, NJ 08854, USA
| | - James V Scicolone
- Department of Chemical and Biochemical Engineering, Rutgers - The State University of New Jersey, Piscataway, NJ 08854, USA
| | - Fernando J Muzzio
- Department of Chemical and Biochemical Engineering, Rutgers - The State University of New Jersey, Piscataway, NJ 08854, USA
| | - Marianthi Ierapetritou
- Department of Chemical and Biomolecular Engineering, University of Delaware, Newark, DE 19716, USA.
| |
Collapse
|
30
|
Yamada M, Badr S, Udugama IA, Fukuda S, Nakaya M, Yoshioka Y, Sugiyama H. A systematic techno-economic approach to decide between continuous and batch operation modes for injectable manufacturing. Int J Pharm 2021; 613:121353. [PMID: 34896214 DOI: 10.1016/j.ijpharm.2021.121353] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/08/2021] [Revised: 11/08/2021] [Accepted: 12/02/2021] [Indexed: 12/23/2022]
Abstract
A comprehensive approach is proposed to systematically determine the optimal mode of operation between continuous and batch injectable manufacturing considering product and market conditions. At the core of this approach are two integrated complete mathematical modules for discrete and continuous injectable manufacturing, which are supplemented with an economic evaluation module that can then be used to explore the impact of all relevant process parameters (e.g., lot-size, number of operators, solubility, product demand, raw material costs). When the developed approach was applied to two case studies, it was found that batch production was preferred at low to moderate solution (raw material) costs. In contrast, at higher solution costs, the preference for batch and continuous production processes changed back and forth as the annual product demand changed. The study also found that continuous production processes became increasingly preferred at medium to large final dosage volumes and a competitive alternative even at moderate solution costs. From a decision-making point of view, batch injectable manufacturing will be preferred over the novel continuous manufacturing technology unless there is a significant economic incentive to overcome the perceived technology risk. The proposed approach is intended as a decision-support tool for pharmaceutical process engineers.
Collapse
Affiliation(s)
- Masahiro Yamada
- Department of Chemical System Engineering, The University of Tokyo, 7-3-1, Hongo, Bunkyo-ku, 113-8656 Tokyo, Japan
| | - Sara Badr
- Department of Chemical System Engineering, The University of Tokyo, 7-3-1, Hongo, Bunkyo-ku, 113-8656 Tokyo, Japan
| | - Isuru A Udugama
- Department of Chemical System Engineering, The University of Tokyo, 7-3-1, Hongo, Bunkyo-ku, 113-8656 Tokyo, Japan
| | - Shouko Fukuda
- Settsu Plant, Shionogi Pharma Co., Ltd., 2-5-1, Mishima, Settsu-Shi, 556-0022 Osaka, Japan
| | - Manabu Nakaya
- Settsu Plant, Shionogi Pharma Co., Ltd., 2-5-1, Mishima, Settsu-Shi, 556-0022 Osaka, Japan
| | - Yasuyuki Yoshioka
- Settsu Plant, Shionogi Pharma Co., Ltd., 2-5-1, Mishima, Settsu-Shi, 556-0022 Osaka, Japan
| | - Hirokazu Sugiyama
- Department of Chemical System Engineering, The University of Tokyo, 7-3-1, Hongo, Bunkyo-ku, 113-8656 Tokyo, Japan.
| |
Collapse
|
31
|
Beke ÁK, Gyürkés M, Nagy ZK, Marosi G, Farkas A. Digital twin of low dosage continuous powder blending - Artificial neural networks and residence time distribution models. Eur J Pharm Biopharm 2021; 169:64-77. [PMID: 34562574 DOI: 10.1016/j.ejpb.2021.09.006] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/10/2021] [Revised: 08/24/2021] [Accepted: 09/17/2021] [Indexed: 10/20/2022]
Abstract
In this paper we present a thorough description of the digital twin development for a continuous pharmaceutical powder blending process in accordance with the Process Analytical Technologies (PAT) and Quality by Design (QbD) guidelines. A low-dosage system of caffeine active pharmaceutical ingredient (API) and dextrose excipient was examined via continuous blending experiments. Near infrared (NIR) spectroscopy-based process analytics were applied; quantitative evaluation of spectra was achieved using multivariate data analysis. The blending system was represented with mechanistic residence time distribution (RTD) models and two types of recurrent artificial neural networks (ANN), experimental datasets were used for model training or fitting and validation. Detailed comparison of the two modelling approaches, the optimization of the model-based digital twin, and efficiency of the soft sensor-based process monitoring is presented through several validating simulations. Both RTD models and nonlinear autoregressive neural networks demonstrated excellent predictive power for the low dosage blending process. RTD models can prove to be more advantageous in industrial development as they are less resource-intensive to develop and prediction accuracy on low concentration levels lacks dependency from the precision of chemometric calibration. Reduced material costs and limited development timeframe render the digital twin an efficient tool in technological development.
Collapse
Affiliation(s)
- Áron Kristóf Beke
- Department of Organic Chemistry and Technology, Budapest University of Technology and Economics (BME), Műegyetem rakpart 3, Budapest H-1111, Hungary
| | - Martin Gyürkés
- Department of Organic Chemistry and Technology, Budapest University of Technology and Economics (BME), Műegyetem rakpart 3, Budapest H-1111, Hungary
| | - Zsombor Kristóf Nagy
- Department of Organic Chemistry and Technology, Budapest University of Technology and Economics (BME), Műegyetem rakpart 3, Budapest H-1111, Hungary
| | - György Marosi
- Department of Organic Chemistry and Technology, Budapest University of Technology and Economics (BME), Műegyetem rakpart 3, Budapest H-1111, Hungary
| | - Attila Farkas
- Department of Organic Chemistry and Technology, Budapest University of Technology and Economics (BME), Műegyetem rakpart 3, Budapest H-1111, Hungary.
| |
Collapse
|
32
|
Rashid MA, White ET, Howes T, Litster JD, Marziano I. Measurement of nucleation kinetics for ibuprofen crystals from ethanol and water-ethanol mixtures. J Drug Deliv Sci Technol 2021. [DOI: 10.1016/j.jddst.2021.102587] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
33
|
Wang LG, Omar C, Litster JD, Li J, Mitchell N, Bellinghausen S, Barrasso D, Salman A, Slade D. Tableting model assessment of porosity and tensile strength using a continuous wet granulation route. Int J Pharm 2021; 607:120934. [PMID: 34310957 DOI: 10.1016/j.ijpharm.2021.120934] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/23/2021] [Revised: 07/20/2021] [Accepted: 07/21/2021] [Indexed: 01/17/2023]
Abstract
This paper presents a comprehensive assessment of the most widely used tablet compaction models in a continuous wet granulation tableting process. The porosity models, tensile strength models and lubricant models are reviewed from the literature and classified based on their formulations i.e. empirical or theoretical and applications, i.e. batch or continuous. The majority of these models are empirical and were initially developed for batch tabletting process. To ascertain their effectiveness and serviceability in the continuous tableting process, a continuous powder processing line of Diamond Pilot Plant (DiPP) installed at The University of Sheffield was used to provide the quantitative data for tablet model assessment. Magnesium stearate (MgSt) is used as a lubricant to investigate its influence on the tensile strength. Whilst satisfactory predictions from the tablet models can be produced, a compromise between the model fidelity and model simplicity needs to be made for a suitable model selection. The Sonnergaard model outperforms amongst the porosity models whilst the Reynolds model produces the best goodness of fitting for two parameters fitting porosity models. An improved tensile strength model is proposed to consider the influence of powder size and porosity in the continuous tableting process.
Collapse
Affiliation(s)
- Li Ge Wang
- Department of Chemical and Biological Engineering, University of Sheffield, UK; Siemens Process Systems Engineering, Hammersmith, London, UK
| | - Chalak Omar
- Department of Chemical and Biological Engineering, University of Sheffield, UK
| | - James D Litster
- Department of Chemical and Biological Engineering, University of Sheffield, UK.
| | - Jianfeng Li
- Siemens Process Systems Engineering, Parsippany, NJ Office, USA
| | - Niall Mitchell
- Siemens Process Systems Engineering, Hammersmith, London, UK
| | | | - Dana Barrasso
- Siemens Process Systems Engineering, Parsippany, NJ Office, USA
| | - Agba Salman
- Department of Chemical and Biological Engineering, University of Sheffield, UK
| | - David Slade
- Siemens Process Systems Engineering, Hammersmith, London, UK
| |
Collapse
|
34
|
Powder composition monitoring in continuous pharmaceutical solid-dosage form manufacturing using state estimation - Proof of concept. Int J Pharm 2021; 605:120808. [PMID: 34144142 DOI: 10.1016/j.ijpharm.2021.120808] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/08/2021] [Revised: 05/25/2021] [Accepted: 06/13/2021] [Indexed: 12/18/2022]
Abstract
In continuous solid-dosage form manufacturing, the powder feeding system is responsible for supplying downstream the correct formulation of the drug product ingredients. The composition of the powder delivered by the feeding system is inferred from the measurements of powder mass flow from the system feeders. The mass flows are, in turn, inferred from the loss in weight measured in the feeder hoppers. Most loss-in-weight feeders post-process the mass flow signal to deliver a smoothed value to the user. However, such estimated mass flows can exhibit a low signal-to-noise ratio. As the feeders are critical elements of the control strategy of the manufacturing line, better instantaneous estimates of mass flow are desirable for improving the quality assurance. In this study, we propose a model-based approach for monitoring the composition of the powder fed to a continuous solid-dosage line. The monitoring system is based on a moving-horizon state estimator, which carries out model-based reconciliation of the feeder mass measurements, thus enabling accurate composition estimation of the powder mixture. Experimental datasets from a direct compression line are used to validate the methodology. Results demonstrate improvement with respect to current industrial solutions.
Collapse
|
35
|
Soft sensor for real-time estimation of tablet potency in continuous direct compression manufacturing operation. Int J Pharm 2021; 602:120624. [PMID: 33892055 DOI: 10.1016/j.ijpharm.2021.120624] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/17/2020] [Revised: 04/13/2021] [Accepted: 04/17/2021] [Indexed: 11/20/2022]
Abstract
One of the critical quality attributes of the solid oral dosage forms produced in continuous direct compression operations is the tablet potency. A novel soft sensor comprising of a combination of first principle-based and empirical models has been developed to enable real-time monitoring of blend and tablet potency, and concentrations of other excipients at various stream levels along the direct compression line. The soft sensor model has only three adjustable parameters, primarily associated with the equipment design and operation, so the model is product agnostic which is key to enable flexible manufacturing. The estimation accuracy of the soft sensor is demonstrated through a series of real time experiments which include steady state and dynamic transitions of potency during the runs, compared with offline analytically tested tablet cores. The results indicate that the proposed soft sensor can be utilized as a robust tool for real-time monitoring of potency, suggesting an extension of its utilization to higher levels of control. Two potential applications of the soft sensor are: 1. An element of a control strategy for product diversion; 2. A predictive model for advanced process control strategy to minimize the variability in tablet composition.
Collapse
|
36
|
Louge MY, Mandur J, Blincoe W, Tantuccio A, Meyer RF. Non-invasive, continuous, quantitative detection of powder level and mass holdup in a metal feed tube. POWDER TECHNOL 2021. [DOI: 10.1016/j.powtec.2020.12.068] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
37
|
Peterwitz M, Schembecker G. Evaluating the potential for optimization of axial back-mixing in continuous pharmaceutical manufacturing. Comput Chem Eng 2021. [DOI: 10.1016/j.compchemeng.2021.107251] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
38
|
Testa CJ, Shvedova K, Hu C, Wu W, Born SC, Takizawa B, Mascia S. Heterogeneous Crystallization as a Process Intensification Technology in an Integrated Continuous Manufacturing Process for Pharmaceuticals. Org Process Res Dev 2021. [DOI: 10.1021/acs.oprd.0c00468] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/30/2022]
Affiliation(s)
- Christopher J. Testa
- CONTINUUS Pharmaceuticals, 25R Olympia Avenue, Woburn, Massachusetts 01801, United States
| | - Khrystyna Shvedova
- CONTINUUS Pharmaceuticals, 25R Olympia Avenue, Woburn, Massachusetts 01801, United States
| | - Chuntian Hu
- CONTINUUS Pharmaceuticals, 25R Olympia Avenue, Woburn, Massachusetts 01801, United States
| | - Wei Wu
- CONTINUUS Pharmaceuticals, 25R Olympia Avenue, Woburn, Massachusetts 01801, United States
| | - Stephen C. Born
- CONTINUUS Pharmaceuticals, 25R Olympia Avenue, Woburn, Massachusetts 01801, United States
| | - Bayan Takizawa
- CONTINUUS Pharmaceuticals, 25R Olympia Avenue, Woburn, Massachusetts 01801, United States
| | - Salvatore Mascia
- CONTINUUS Pharmaceuticals, 25R Olympia Avenue, Woburn, Massachusetts 01801, United States
| |
Collapse
|
39
|
Tian G, Koolivand A, Gu Z, Orella M, Shaw R, O’Connor TF. Development of an RTD-Based Flowsheet Modeling Framework for the Assessment of In-Process Control Strategies. AAPS PharmSciTech 2021; 22:25. [PMID: 33400033 DOI: 10.1208/s12249-020-01913-8] [Citation(s) in RCA: 9] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/27/2020] [Accepted: 12/21/2020] [Indexed: 11/30/2022] Open
Abstract
Continuous manufacturing (CM) is an emerging technology which can improve pharmaceutical manufacturing and reduce drug product quality issues. One challenge that needs to be addressed when adopting CM technology is material traceability through the entire continuous process, which constitutes one key aspect of control strategy. Residence time distribution (RTD) plays an important role in material traceability as it characterizes the material spreading through the process. The propagation of upstream disturbances could be predictively tracked through the entire process by convolution of the disturbance and the RTD. The present study sets up the RTD-based modeling framework in a commonly used process modeling environment, gPROMS, and integrates it with existing modules and built-in tools (e.g., parameter estimation). Concentration calculations based on the convolution integral requires access to historical stream property information, which is not readily available in flowsheet modeling platforms. Thus, a novel approach is taken whereby a partial differential equation is used to propagate and store historical data as the simulation marches forward in time. Other stream properties not modeled by an RTD are determined in auxiliary modules. To illustrate the application of the framework, an integrated RTD-auxiliary model for a continuous direct compression manufacturing line was developed. An excellent agreement was found between the model predictions and experiments. The validated model was subsequently used to assess in-process control strategies for feeder and material traceability through the process. Our simulation results show that the employed modeling approach facilitates risk-based assessment of the continuous line by promoting our understanding on the process.
Collapse
|
40
|
Furukawa R, Singh R, Ierapetritou M. Effect of material properties on the residence time distribution (RTD) of a tablet press feed frame. Int J Pharm 2020; 591:119961. [DOI: 10.1016/j.ijpharm.2020.119961] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/27/2020] [Revised: 09/18/2020] [Accepted: 10/05/2020] [Indexed: 11/24/2022]
|
41
|
Gyürkés M, Madarász L, Köte Á, Domokos A, Mészáros D, Beke ÁK, Nagy B, Marosi G, Pataki H, Nagy ZK, Farkas A. Process Design of Continuous Powder Blending Using Residence Time Distribution and Feeding Models. Pharmaceutics 2020; 12:pharmaceutics12111119. [PMID: 33233635 PMCID: PMC7699818 DOI: 10.3390/pharmaceutics12111119] [Citation(s) in RCA: 12] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/26/2020] [Revised: 11/18/2020] [Accepted: 11/19/2020] [Indexed: 11/16/2022] Open
Abstract
The present paper reports a thorough continuous powder blending process design of acetylsalicylic acid (ASA) and microcrystalline cellulose (MCC) based on the Process Analytical Technology (PAT) guideline. A NIR-based method was applied using multivariate data analysis to achieve in-line process monitoring. The process dynamics were described with residence time distribution (RTD) models to achieve deep process understanding. The RTD was determined using the active pharmaceutical ingredient (API) as a tracer with multiple designs of experiment (DoE) studies to determine the effect of critical process parameters (CPPs) on the process dynamics. To achieve quality control through material diversion from feeding data, soft sensor-based process control tools were designed using the RTD model. The operation block model of the system was designed to select feasible experimental setups using the RTD model, and feeder characterizations as digital twins, therefore visualizing the output of theoretical setups. The concept significantly reduces the material and instrumental costs of process design and implementation.
Collapse
|
42
|
Pawar P, Clancy D, Gorringe L, Barlow S, Hesketh A, Elkes R. Development and Scale-Up of Diversion Strategy for Twin Screw Granulation in Continuous Manufacturing. J Pharm Sci 2020; 109:3439-3450. [PMID: 32798502 DOI: 10.1016/j.xphs.2020.08.004] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/21/2020] [Revised: 07/07/2020] [Accepted: 08/07/2020] [Indexed: 11/28/2022]
Abstract
Successful implementation of Continuous Manufacturing technology requires real time product quality monitoring that can result into rejection strategies for material manufactured outside process control limits. In a twin screw granulation process, parameters like water content, powder feed rate, and granulator screw speed can influence granule quality. Deviations in any of these parameters from the set-point may affect granule quality. Having a sound diversion strategy in place can help divert these implicated granules to waste. Residence time distribution experiments were conducted on a 16-mm Thermo Fisher twin screw granulator (TSG) for a range of process parameters, and the data was modelled to predict the needed diversion time as a function of process parameters. Scale-up from the 16-mm to 24-mm granulator was evaluated and data was found to scale based on mass per unit volume of granulator (channel fill), thus enabling 16-mm data to scale to 24-mm. The diversion strategy proposed is based on utilizing a wash out curve derived from residence time distribution to quantify the maximum concentration of implicated material that could be present in the next downstream unit operation(s) (e.g. a fluid bed dryer) and ensuring it is less than a suitable threshold to prevent product quality impact.
Collapse
|
43
|
Bhalode P, Ierapetritou M. Discrete element modeling for continuous powder feeding operation: Calibration and system analysis. Int J Pharm 2020; 585:119427. [PMID: 32473969 DOI: 10.1016/j.ijpharm.2020.119427] [Citation(s) in RCA: 16] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/17/2020] [Revised: 05/05/2020] [Accepted: 05/09/2020] [Indexed: 11/29/2022]
Abstract
Research emphases on extensive experimental studies and modeling efforts have been on the rise for the development of accurate predictive models of pharmaceutical unit operations and 'digital-twin' framework for continuous manufacturing lines. These exhaustive studies have been conducted at different process conditions to acquire comprehensive knowledge of effects of process parameters on the overall process dynamics. However, there still lacks a detailed understanding of material property effects of pharmaceutical powders on process operation. To address this issue, a discrete element modeling (DEM) approach combined with material calibration is applied for simulation of feeder unit to obtain particle-level insight into effects of material properties on feeder performance with focus on particle flow and powder mixing within the feeder unit. Bulk calibration is implemented to accurately represent powder material properties within the DEM framework. Different refill situations are simulated using DEM to observe powder mixing, measured at the outlet. Feeder DEM simulations are further applied to understand correlations of material properties on feeder operation. These studies provide a detailed physical insight and particle-scale information into the powder mechanics during powder feeding operation.
Collapse
Affiliation(s)
- Pooja Bhalode
- Department of Chemical and Biochemical Engineering, Rutgers University, Piscataway, NJ 08854, USA
| | - Marianthi Ierapetritou
- Department of Chemical and Biochemical Engineering, Rutgers University, Piscataway, NJ 08854, USA.
| |
Collapse
|
44
|
Escotet-Espinoza MS, Scicolone JV, Moghtadernejad S, Sanchez E, Cappuyns P, Van Assche I, Di Pretoro G, Ierapetritou M, Muzzio FJ. Improving Feedability of Highly Adhesive Active Pharmaceutical Ingredients by Silication. J Pharm Innov 2020. [DOI: 10.1007/s12247-020-09448-y] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|
45
|
Bascone D, Galvanin F, Shah N, Garcia-Munoz S. Hybrid Mechanistic-Empirical Approach to the Modeling of Twin Screw Feeders for Continuous Tablet Manufacturing. Ind Eng Chem Res 2020. [DOI: 10.1021/acs.iecr.0c00420] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/12/2022]
Affiliation(s)
- Davide Bascone
- Centre for Process System Engineering, Department of Chemical Engineering, Imperial College London, London SW7 2AZ, United Kingdom
| | - Federico Galvanin
- Centre for Process System Engineering, Department of Chemical Engineering, University College London (UCL), London WC1E 6BT, United Kingdom
| | - Nilay Shah
- Centre for Process System Engineering, Department of Chemical Engineering, Imperial College London, London SW7 2AZ, United Kingdom
| | - Salvador Garcia-Munoz
- Eli Lilly and Company, Lilly Research Laboratories, Indianapolis, Indiana 46285, United States
| |
Collapse
|
46
|
Vanhoorne V, Vervaet C. Recent progress in continuous manufacturing of oral solid dosage forms. Int J Pharm 2020; 579:119194. [PMID: 32135231 DOI: 10.1016/j.ijpharm.2020.119194] [Citation(s) in RCA: 44] [Impact Index Per Article: 8.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/20/2019] [Revised: 02/28/2020] [Accepted: 02/29/2020] [Indexed: 12/28/2022]
Abstract
Continuous drug product manufacturing is slowly being implemented in the pharmaceutical industry. Although the benefits related to the quality and cost of continuous manufacturing are widely recognized, several challenges hampered the widespread introduction of continuous manufacturing of drug products. Current review presents an overview of state-of-the art research, equipment, process analytical technology implementations and advanced control strategies. Additionally, guidelines and regulatory viewpoints on implementation of continuous manufacturing in the pharmaceutical industry are discussed.
Collapse
Affiliation(s)
- V Vanhoorne
- Laboratory of Pharmaceutical Technology, Ghent University
| | - C Vervaet
- Laboratory of Pharmaceutical Technology, Ghent University.
| |
Collapse
|
47
|
Determining key parameters of continuous wet granulation for tablet quality and productivity: A case in ethenzamide. Int J Pharm 2020; 579:119160. [PMID: 32081803 DOI: 10.1016/j.ijpharm.2020.119160] [Citation(s) in RCA: 13] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/10/2019] [Revised: 01/29/2020] [Accepted: 02/16/2020] [Indexed: 11/24/2022]
Abstract
This paper aims to determine key parameters that affect tablet quality and productivity in continuous tablet manufacturing. Experiments were performed based on design of experiments using a continuous high-shear granulator and ethenzamide as the active pharmaceutical ingredient. To guide a systematic and comprehensive parameter analysis, a parameter framework was defined that comprised five input parameters on raw material properties and process parameters, 11 intermediate parameters on granule properties, and 11 output parameters on tablet quality and productivity. The interrelationships were analyzed statistically and were described as matrix functions. The liquid/solid ratio was the key parameter that affected circularity, density, and flowability as the granule properties, and disintegration and dissolution as the tablet quality. The maximum acceptable manufacturing rate that governs productivity was also affected by the liquid/solid ratio. Circularity was found to affect disintegration and dissolution. This result was specific to the setup of the study, but suggested development opportunities for a new process analytical technology system/quality-by-design application based on circularity. In addition, practical findings were obtained as follows: (1) high-speed manufacturing favored a lower liquid/solid ratio, and (2) high circularity slowed down disintegration/dissolution. This obtained knowledge will enhance the applicability of continuous technology in an actual manufacturing environment.
Collapse
|
48
|
Karttunen AP, Poms J, Sacher S, Sparén A, Ruiz Samblás C, Fransson M, Martin De Juan L, Remmelgas J, Wikström H, Hsiao WK, Folestad S, Korhonen O, Abrahmsén-Alami S, Tajarobi P. Robustness of a continuous direct compression line against disturbances in feeding. Int J Pharm 2020; 574:118882. [DOI: 10.1016/j.ijpharm.2019.118882] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/18/2019] [Revised: 11/12/2019] [Accepted: 11/13/2019] [Indexed: 11/29/2022]
|
49
|
Galbraith S, Park S, Huang Z, Liu H, Meyer R, Metzger M, Flamm M, Hurley S, Yoon S. Linking process variables to residence time distribution in a hybrid flowsheet model for continuous direct compression. Chem Eng Res Des 2020. [DOI: 10.1016/j.cherd.2019.10.026] [Citation(s) in RCA: 17] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
50
|
Ochsenbein DR, Billups M, Hong B, Schäfer E, Marchut AJ, Lyngberg OK. Industrial application of heat- and mass balance model for fluid-bed granulation for technology transfer and design space exploration. Int J Pharm X 2019; 1:100028. [PMID: 31517293 PMCID: PMC6733368 DOI: 10.1016/j.ijpx.2019.100028] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/08/2019] [Revised: 08/06/2019] [Accepted: 08/09/2019] [Indexed: 11/28/2022] Open
Abstract
This work demonstrates the application of state-of-the-art modeling techniques in pharmaceutical manufacturing for fluid bed granulation at varying scales to successfully predict process conditions and ultimately replace experiments during a technology transfer of five products. We describe a mathematical model able to simulate the time-dependent moisture profile in a fluid bed granulation process. The applicability of this model is then demonstrated by calibrating and validating it over a range of operating conditions, manufacturing scales, and formulations. The inherent capability of the moisture profile to serve as a simple, scale-independent surrogate is shown by the large number of successful scale-ups and transfers. A methodology to use this 'digital twin' to systematically explore the effects of uncertainty inherent in the process input and model parameter spaces and their impact on the process outputs is described. Two case studies exemplifying the utilization of the model in industrial practice to assess process robustness are provided. Lastly, a pathway to leverage model results to establish proven acceptable ranges for individual parameters is outlined.
Collapse
Affiliation(s)
- David R. Ochsenbein
- Janssen-Cilag AG, Pharmaceutical Companies of Johnson & Johnson, Switzerland
| | - Matthew Billups
- Janssen Supply Group, LLC, Pharmaceutical Companies of Johnson & Johnson, United States
| | - Bingbing Hong
- Xian-Janssen Pharmaceutical Ltd., Pharmaceutical Companies of Johnson & Johnson, China
| | - Elisabeth Schäfer
- Janssen Pharmaceutica NV, Pharmaceutical Companies of Johnson & Johnson, Belgium
| | - Alexander J. Marchut
- Janssen Supply Group, LLC, Pharmaceutical Companies of Johnson & Johnson, United States
| | - Olav K. Lyngberg
- Janssen Supply Group, LLC, Pharmaceutical Companies of Johnson & Johnson, United States
| |
Collapse
|